Introduction
Poor aqueous solubility remains a significant barrier to the oral delivery of Biopharmaceutics Classification System (BCS) Class II and IV drugs, often resulting in suboptimal dissolution, limited absorption, and inadequate…

Poor aqueous solubility remains a significant barrier to the oral delivery of Biopharmaceutics Classification System (BCS) Class II and IV drugs, often resulting in suboptimal dissolution, limited absorption, and inadequate…